Geftinat 250mg Tablet
In stock
Description
Geftinat 250mg (containing Gefitinib) is an antineoplastic agent primarily used to treat non-small cell lung cancer (NSCLC). It functions as a targeted therapy by acting as a kinase inhibitor.
Specifications
| Strength | 250mg Tablet |
|---|---|
| Main Ingreditnts | Gefitinib (250mg) |
| Storage | Store below 30°C, Cool & Dry Place |
| Uses | Non-small cell lung cancer. |
| Administration | Oral (tablet). |
| Packaging | 30 Tablets (Bottle/Strip) |
